 | Up a level |
Journal Article
Cosgarea, I, Zimmer, L., Weide, B., Gutzmer, R., Heinzerling, L., Weishaupt, C., Pfoehler, C., Gesierich, A., Herbst, R., Kaehler, K., Schlaak, M., Loquai, C., Utikal, J., Kaatz, M., Berking, C., Kreuter, A., Ulrich, J., Mohr, P., Dippel, E., Livingstone, E., Weichenthal, M., Schadendorf, D. and Ugurel, S. (2017). Interleukin-2 and Checkpoint Inhibition as a successful Therapy Sequence for metastatic Melanoma: Case Report and retrospective Analysis in 52 Patients. J. Dtsch. Dermatol. Ges., 15. S. 16 - 18. HOBOKEN: WILEY. ISSN 1610-0387
Hassel, J., Forschner, A., Bluhm, L., Heinzerling, L., Zimmer, L., Utikal, J., Kaehler, K., Schlaak, M., Loquai, C., Gutzmer, R., Kieker, F., Berking, C., Bender, A., Schneider, L., Enk, A., Garbe, C., Weichenthal, M., Schadendorf, D., Hauschild, A. and Mohr, P. (2016). Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP). J. Dtsch. Dermatol. Ges., 14. S. 9 - 10. HOBOKEN: WILEY-BLACKWELL. ISSN 1610-0387
Kramer, R., Mentzer, D., Erdmann, M., Knauss, S., Broeckelmann, P. J., Hassel, J. C., Ugurel, S., Pavel, M., Nickel, F. T., Landendinger, M., Fuchs, F., Meidenbauer, N., Jefremow, A., Manger, B., Gutzmer, R., Loquai, C., Kaehler, K., Zimmer, L., Berking, C., Keller-Stanislawski, B. and Heinzerling, L. (2020). SERIO - Side Effect Registry Immuno-Oncology Side Effect Registry for rare, severe and complex Side Effects of Immunotherapy. J. Dtsch. Dermatol. Ges., 18. S. 14 - 16. HOBOKEN: WILEY. ISSN 1610-0387
Zaremba, A., Martaki, A., Salzmann, M., Baroudjian, B., Sachse, M. M., Gesierich, A., Reinhardt, L., Meier, F., Hassel, J. C., Ugurel, S., Roesch, A., Schadendorf, D., Livingstone, E., Broeckelmann, P., Kramer, R., Heinzerling, L. and Zimmer, L. (2020). Agranulocytosis with Immune Checkpoint-Blockade - a retrospective, multicenter Evaluation. J. Dtsch. Dermatol. Ges., 18. S. 15 - 17. HOBOKEN: WILEY. ISSN 1610-0387